Literature DB >> 26885169

Snare sheath versus evolution sheath in transvenous lead extraction.

Jihua Kong1, Yilun Tian1, Fei Guo1, Feng Ze1, Jiangbo Duan1, Long Wang1, Xuebin Li1, Jihong Guo1.   

Abstract

Lead extraction remains a challenging procedure with significant success. Owing to the increasing use of cardiac implantable electronic devices, there is a growing need for effective techniques management, to avoid the occurrence of device-related complications and lead dysfunction. We made a comparison of Evolution sheath and Needles Eye Snare sheath (abbreviated to Snare sheath) by analyzed the results using two kind of the methods in the Cardiology Center of Peking University People's Hospital. In the retrospective study we evaluated patients who underwent lead extraction from July 2013 to July 2014. Those who underwent lead removal without using evolution or snare were excluded. Primary endpoints included total exposure time, operation time, and complications. Data on clinical characteristics, indications, and outcomes were prospectively collected and analyzed. A total of 76 patients were included in the study (65.8% male; aged 68.1±14.34 years old). Snare and Evolution were used in 59 and 17 patients, respectively. A total of 134 leads were removed with 103 leads (76.87%) extracted using the Snare sheath. Lead age was 10.8±7.0 years. Complete extraction was observed in 67 patients of 124 leads. Evolution sheath was associated with significantly lower complication even after adjustment of the number of leads, type of leads, and lead age, compared to the Snare group (P<0.05). In the Snare sheath group, mortality rate was 1.69% and minor complication rate was 3.39%. When compared to the Snare sheath, lead extraction with the Evolution sheath has less X-ray exposure time and less operation time (P<0.05), while with a higher success rate (P<0.05). Besides, the Evolution group has fewer major and minor complications.

Entities:  

Keywords:  Lead extraction; evolution; pacemaker; snare

Year:  2015        PMID: 26885169      PMCID: PMC4724015     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  28 in total

1.  Current practice in transvenous lead extraction: a European Heart Rhythm Association EP Network Survey.

Authors:  Maria Grazia Bongiorni; Carina Blomström-Lundqvist; Charles Kennergren; Nikolaos Dagres; Laurent Pison; Jesper Hastrup Svendsen; Angelo Auricchio
Journal:  Europace       Date:  2012-06       Impact factor: 5.214

2.  Transvenous lead extraction: Heart Rhythm Society expert consensus on facilities, training, indications, and patient management: this document was endorsed by the American Heart Association (AHA).

Authors:  Bruce L Wilkoff; Charles J Love; Charles L Byrd; Maria Grazia Bongiorni; Roger G Carrillo; George H Crossley; Laurence M Epstein; Richard A Friedman; Charles E H Kennergren; Przemyslaw Mitkowski; Raymond H M Schaerf; Oussama M Wazni
Journal:  Heart Rhythm       Date:  2009-05-22       Impact factor: 6.343

3.  The challenges of transvenous lead extraction.

Authors:  Melanie Maytin; Laurence M Epstein
Journal:  Heart       Date:  2011-03       Impact factor: 5.994

4.  Update on indications, techniques, and complications of cardiac implantable device lead extraction.

Authors:  Charles J Love
Journal:  Curr Treat Options Cardiovasc Med       Date:  2012-10

5.  Transvenous lead extractions: comparison of laser vs. mechanical approach.

Authors:  Christoph T Starck; Hector Rodriguez; David Hürlimann; Jürg Grünenfelder; Jan Steffel; Sacha P Salzberg; Volkmar Falk
Journal:  Europace       Date:  2013-04-12       Impact factor: 5.214

6.  Complete removal as a routine treatment for any cardiovascular implantable electronic device-associated infection.

Authors:  Maximilian Pichlmaier; Ludmilla Knigina; Ingo Kutschka; Christoph Bara; Hanno Oswald; Gunnar Klein; Theodosius Bisdas; Axel Haverich
Journal:  J Thorac Cardiovasc Surg       Date:  2011-05-12       Impact factor: 5.209

7.  Predictors of mortality in patients with cardiovascular implantable electronic device infections.

Authors:  Ammar Habib; Katherine Y Le; Larry M Baddour; Paul A Friedman; David L Hayes; Christine M Lohse; Walter R Wilson; James M Steckelberg; M Rizwan Sohail
Journal:  Am J Cardiol       Date:  2012-12-29       Impact factor: 2.778

8.  Impact of timing of device removal on mortality in patients with cardiovascular implantable electronic device infections.

Authors:  Katherine Y Le; Muhammad R Sohail; Paul A Friedman; Daniel Z Uslan; Stephen S Cha; David L Hayes; Walter R Wilson; James M Steckelberg; Larry M Baddour
Journal:  Heart Rhythm       Date:  2011-05-27       Impact factor: 6.343

9.  Pacemaker and defibrillator lead extraction: predictors of mortality during follow-up.

Authors:  Shoaib Hamid; Aruna Arujuna; Matthew Ginks; Mark McPhail; Nikhil Patel; Cliff Bucknall; Christopher Rinaldi
Journal:  Pacing Clin Electrophysiol       Date:  2009-11-02       Impact factor: 1.976

10.  Update on cardiovascular implantable electronic device infections and their management: a scientific statement from the American Heart Association.

Authors:  Larry M Baddour; Andrew E Epstein; Christopher C Erickson; Bradley P Knight; Matthew E Levison; Peter B Lockhart; Frederick A Masoudi; Eric J Okum; Walter R Wilson; Lee B Beerman; Ann F Bolger; N A Mark Estes; Michael Gewitz; Jane W Newburger; Eleanor B Schron; Kathryn A Taubert
Journal:  Circulation       Date:  2010-01-04       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.